Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study

期刊论文
出版模式：

开放获取
发表日期：

2024年5月10日

查看全文

Filipa Lynce,
Candace Mainor,
Renee N. Donahue,
Xue Geng,
Greg Jones,
Ilana Schlam,
Hongkun Wang,
Nicole J. Toney,
Caroline Jochems,
Jeffrey Schlom,
Jay Zeck,
Christopher Gallagher,
Rita Nanda,
Deena Graham,
Erica M. Stringer-Reasor,
Neelima Denduluri,
Julie Collins,
Ami Chitalia,
Shruti Tiwari,
Raquel Nunes,
Rebecca Kaltman,
Katia Khoury,
Margaret Gatti-Mays,
Paolo Tarantino,
Sara M. Tolaney,
Sandra M. Swain,
Paula Pohlmann,
Heather A. Parsons,
Claudine Isaacs

本文未提供摘要，请点击“查看全文”查看完整内容。